BRIEF published on 03/18/2026 at 07:35, 1 month 26 days ago Sensorion publie ses résultats 2025 et les dernières nouvelles de l'entreprise Résultats Financiers Thérapie Génique Sensorion Perte Auditive Investissements Sanofi
PRESS RELEASE published on 03/18/2026 at 07:30, 1 month 26 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion publie ses résultats annuels 2025, met à jour sa feuille de route et annonce la publication du rapport annuel, avec des avancées significatives dans les thérapies géniques pour la perte auditive Résultats Annuels Bilan Financier Thérapies Géniques Sensorion Perte Auditive
PRESS RELEASE published on 03/18/2026 at 07:30, 1 month 26 days ago Inside Information / News release on accounts, results Sensorion reports full-year 2025 results, provides corporate update, and announces release of annual report. Key milestones in gene therapies for hearing loss. Financial highlights and future expectations highlighted Financial Highlights Full-year Results Sensorion Gene Therapies Future Milestones
BRIEF published on 02/17/2026 at 07:35, 2 months 24 days ago Leadership Transition at Sensorion amid Strategic Focus on Hearing Loss Therapies Biotechnology Gene Therapy Leadership Change Sensorion Hearing Loss
BRIEF published on 02/17/2026 at 07:35, 2 months 24 days ago Sensorion annonce des changements dans sa direction Sensorion Changement Direction Thérapie Auditive Financement Sanofi Pipeline Médical
BRIEF published on 02/17/2026 at 07:35, 2 months 24 days ago Sensorion announces changes in its management Change Of Direction Sensory Auditory Therapy Sanofi Financing Medical Pipeline
BRIEF published on 02/17/2026 at 07:35, 2 months 24 days ago Transition de direction chez Sensorion dans un contexte de recentrage stratégique sur les thérapies contre la perte auditive Biotechnologie Thérapie Génique Changement De Leadership Sensorion Perte Auditive
PRESS RELEASE published on 02/17/2026 at 07:30, 2 months 24 days ago Inside Information / Other news releases Sensorion announces Nawal Ouzren stepping down as CEO for personal reasons. Amit Munshi to serve as Interim CEO. Sanofi-led financing for pipeline assets Leadership Changes Sanofi Sensorion Amit Munshi Nawal Ouzren
PRESS RELEASE published on 02/17/2026 at 07:30, 2 months 24 days ago Informations privilégiées / Autres communiqués Sensorion annonce des changements dans sa direction avec le départ de Nawal Ouzren et la prise de fonction par Amit Munshi en tant que Directeur Général par intérim Direction Sensorion Changements Amit Munshi Nawal Ouzren
BRIEF published on 02/06/2026 at 07:35, 3 months 7 days ago Sensorion participera à la 49e réunion annuelle d'hiver de l'ARO. Biotechnologie Thérapie Génique Sensorion Perte Auditive Réunion ARO
Published on 05/14/2026 at 04:15, 1 hour 25 minutes ago Battery X Metals Announces Corporate Awareness Engagement
Published on 05/14/2026 at 03:15, 2 hours 25 minutes ago Jaguar Delivers Strong Adjusted Earnings and Strategic Production Restart of MTL (Turmalina Mine) in Q1 2026
Published on 05/13/2026 at 23:30, 6 hours 10 minutes ago CCL Industries Announces Results for 2026 First Quarter
Published on 05/14/2026 at 03:20, 2 hours 19 minutes ago TCL Electronics (01070.HK) Maintains Strong Growth in Q1 2026
Published on 05/14/2026 at 01:05, 4 hours 34 minutes ago THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 22:20, 7 hours 19 minutes ago Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:18, 9 hours 21 minutes ago EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 18:02, 11 hours 38 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 11 hours 40 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 11 hours 55 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
